Risk factors for clinician-reported symptom clusters in patients with advanced head and neck cancer in a phase 3 randomized clinical trial: RTOG 0129-Reference-Cited by-同舟云学术

Risk factors for clinician-reported symptom clusters in patients with advanced head and neck cancer in a phase 3 randomized clinical trial: RTOG 0129

Published:2013-12-11 Issue:6 Volume:120 Page:848-854
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Xiao Canhua¹,Hanlon Alexandra²,Zhang Qiang³,Movsas Benjamin⁴,Ang Kian⁵,Rosenthal David I.⁵,Nguyen-Tan P. Félix⁶,Kim Harold⁷,Le Quynh⁸,Bruner Deborah Watkins¹

Affiliation:

1. School of Nursing; Emory University; Atlanta Georgia

2. School of Nursing; University of Pennsylvania; Philadelphia Pennsylvania

3. RTOG Statistical Center; Philadelphia Pennsylvania

4. Department of Radiation Oncology; Henry Ford Hospital; Detroit Michigan

5. University of Texas MD Anderson Cancer Center; Houston Texas

6. Centre Hospitalier de l'Université de Montréal (CHUM); Montreal Canada

7. Wayne State University, Karmanos Cancer Institute; Detroit Michigan

8. Stanford University; Stanford California

Funder

American Nursing Foundation

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.28500/fullpdf

Reference38 articles.

1. National Cancer Database report on cancer of the head and neck: 10-year update;Cooper;Head Neck,2009

2. Physical functioning of elderly cancer patients prior to diagnosis and following initial treatment;Given;Nurs Res,2001

3. Symptom clusters in patients with head and neck cancer receiving concurrent chemoradiotherapy;Xiao;Oral Oncol,2013

4. Symptom clusters and relationships to symptom interference with daily life in Taiwanese lung cancer patients;Wang;J Pain Symptom Manage,2008

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations of differentially expressed genes with psychoneurological symptoms in patients with head and neck cancer: A longitudinal study;Journal of Psychosomatic Research;2023-12

2. A Preliminary Validation of an Optimal Cutpoint in Total Number of Patient-Reported Symptoms in Head and Neck Cancer for Effective Alignment of Clinical Resources With Patients’ Symptom Burden;Cancer Care Research Online;2023-11-22

3. Human papillomavirus-driven repression of NRF2 signalling confers chemo-radio sensitivity and predicts prognosis in head and neck squamous cell carcinoma;Free Radical Biology and Medicine;2023-08

4. Associations of inflammation with neuropsychological symptom cluster in patients with Head and neck cancer: A longitudinal study;Brain, Behavior, & Immunity - Health;2023-07

5. Symptoms, symptom clusters and associated factors among cancer patients receiving immune checkpoint inhibitor therapy: A cross-sectional survey;European Journal of Oncology Nursing;2023-04